(Q58023949)
Statements
Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy (English)
Dietger Niederwieser
Hagop M Kantarjian
Michele Baccarani
Jeffrey H Lipton
Jane F Apperley
Thierry Facon
Stuart L Goldberg
Francisco Cervantes
Richard T Silver
Richard M Stone
Timothy P Hughes
Martin C Muller
Rana Ezzeddine
Athena M Countouriotis
Neil P Shah
30 November 2006